Folate Metabolism, Mitochondrial Disease and Autism
Dr. Richard Frye discusses folate metabolism and mitochondrial disease in autism. He details acyl-carnitine profiles as potential biomarkers for acquired mitochondrial disease and provides and example of translational research before the Q&A.
Watch Next
Sustained Potential as a Biomarker of Language Functioning in Autism
Vardan Arutiunian, PhD
Sustained potential (SP) is a neural response to periodic auditory stimuli registered with EEG 40Hz Auditory Steady-State Response. The talk…
Towards the Development of a Diagnostic Test for Autism Spectrum Disorder – Data Science Meets Metabolomics
Juergen Hahn, MS, PhD
Juergen Hahn, Ph.D., ARI Scientific Advisory Board member, discusses how using machine learning can lead to biomarker discoveries in autism research.…
Improving Clinical Understanding of Autism
James McPartland, PhD
James McPartland, Ph.D., discusses current limitations in autism diagnosis and treatment, noting their reliance on behavioral observations despite the condition’s…
Biomarkers start telling us a story: Autism pathophysiology revisited
Antonio Persico, MD
Antonio Persico, MD, a recent ARI Research Grant recipient, explores the role of biomarkers in understanding autism pathophysiology. He discusses…